CompanyTrack
O

OMASS THERAPEUTICS LIMITED

Active Oxford

Research and experimental development on biotechnology

60 employees Website
Life sciences and medical technology Research and experimental development on biotechnology
O

OMASS THERAPEUTICS LIMITED

Research and experimental development on biotechnology

Founded 26 Feb 2016 Active Oxford, England 60 employees omass.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 11 Sept 2025
Confirmation Statement Submitted 21 Mar 2025
Net assets £55.14M £13.93M 2024 year on year
Total assets £59.19M £13.99M 2024 year on year
Total Liabilities £4.04M £51.58K 2024 year on year
Charges 1
1 satisfied

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

Building 4000 John Smith Drive Oxford Business Park South Oxford OX4 2GX England

Website

omass.com

Credit Report

Discover OMASS THERAPEUTICS LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2016–2024)

Cash in Bank

£49.30M

Increased by £12.06M (+32%)

Net Assets

£55.14M

Increased by £13.93M (+34%)

Total Liabilities

£4.04M

Increased by £51.58k (+1%)

Turnover

N/A

Employees

60

Debt Ratio

7%

Decreased by 2 (-22%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

24 Allotments 62,346,052 Shares £118468582.55m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
28 Oct 20257,477£2k£0.3
31 Jul 202420,000,000£34.20m£1.71
7 Dec 2023386£115.8£0.3
12 Nov 2023319£95.7£0.3
18 Apr 20233,508,772£6.00m£1.71

Officers

Officers

12 active 7 resigned
Status
Birgitte VolckDirectorDanishDenmark631 Feb 2025Active
Carol Anne SchaferDirectorAmericanUnited States627 Jul 2025Active
Christopher Philip AshtonDirectorBritishEngland6614 Oct 2020Active
Diana BernsteinDirectorAmericanUnited States3919 Apr 2022Active
Edward Eliot HodgkinDirectorBritishEngland6224 May 2017Active
James Arthur GeraghtyDirectorAmericanUnited States719 May 2023Active
Jonathan Deane Montagu DaoustDirectorBritishGermany5030 May 2019Active
Laia Crespo-martinDirectorSpanishFrance5119 Apr 2022Active

Shareholders

Shareholders (98)

The Chancellors, Masters & Scholars Of The University Of Oxford
0.1%
116,95921 Mar 2025
William Graham Richards
0.0%
34,65421 Mar 2025
Viviane Mignone
0.0%
24,70721 Mar 2025

Persons with Significant Control

Persons with Significant Control (2)

2 Active 1 Ceased

Oxford Science Enterprises Plc

United Kingdom

Active
Notified 11 Sept 2018
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Syncona Limited

British Channel Islands

Active
Notified 11 Sept 2018
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Oxford Sciences Innovation Plc

Ceased 11 Sept 2018

Ceased

Group Structure

Group Structure

SYNCONA LIMITED british channel islands
OMASS THERAPEUTICS LIMITED Current Company
SVS RESEARCH HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

Charges

Charges

1 satisfied

Documents

Company Filings

DateCategoryDescriptionDocument
12 Dec 2025CapitalAllotment of shares (GBP 89,827.529) on 2025-12-05View(4 pages)
3 Dec 2025CapitalCapital Name Of Class Of SharesView(2 pages)
5 Nov 2025CapitalCapital Name Of Class Of SharesView(2 pages)
28 Oct 2025CapitalAllotment of shares (GBP 89,817.693) on 2025-10-28View(4 pages)
24 Oct 2025CapitalCapital Name Of Class Of SharesView(2 pages)
12 Dec 2025 Capital

Allotment of shares (GBP 89,827.529) on 2025-12-05

3 Dec 2025 Capital

Capital Name Of Class Of Shares

5 Nov 2025 Capital

Capital Name Of Class Of Shares

28 Oct 2025 Capital

Allotment of shares (GBP 89,817.693) on 2025-10-28

24 Oct 2025 Capital

Capital Name Of Class Of Shares

Recent Activity

Latest Activity

Allotment of shares (GBP 89,827.529) on 2025-12-05

2 months ago on 12 Dec 2025

Capital Name Of Class Of Shares

2 months ago on 3 Dec 2025

Capital Name Of Class Of Shares

3 months ago on 5 Nov 2025

Allotment of shares (GBP 89,817.693) on 2025-10-28

3 months ago on 28 Oct 2025

Capital Name Of Class Of Shares

3 months ago on 24 Oct 2025